Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
HumanPheno	Premature thelarche	KMT2D KDM6A ALK	2.90e-05	17	19	3	HP:0010314
HumanPheno	Bilateral tonic-clonic seizure with focal onset	NHLRC1 KMT2D SZT2 KDM6A	3.34e-05	52	19	4	HP:0007334
HumanPheno	Abnormal alveolar type II pneumocyte morphology	KMT2D KDM6A	3.95e-05	3	19	2	HP:0033245
HumanPheno	Decreased proportion of CD4-positive, alpha-beta memory T cells	KMT2D KDM6A	3.95e-05	3	19	2	HP:0410386
HumanPheno	Type II pneumocyte hyperplasia	KMT2D KDM6A	3.95e-05	3	19	2	HP:0033328
HumanPheno	Scimitar anomaly	KMT2D KDM6A	7.87e-05	4	19	2	HP:0011626
HumanPheno	Absent pubertal growth spurt	KMT2D KDM6A	1.31e-04	5	19	2	HP:0031087
HumanPheno	Branchial sinus	KMT2D KDM6A	1.31e-04	5	19	2	HP:0100272
HumanPheno	Recurrent aspiration pneumonia	NHLRC1 KMT2D KDM6A	1.51e-04	29	19	3	HP:0002100
HumanPheno	Eversion of lateral third of lower eyelids	KMT2D KDM6A	1.96e-04	6	19	2	HP:0007655
HumanPheno	Bilateral renal hypoplasia	KMT2D KDM6A	1.96e-04	6	19	2	HP:0012584
HumanPheno	Decreased proportion of memory T cells	KMT2D KDM6A	2.74e-04	7	19	2	HP:0032183
HumanPheno	Abnormal pulmonary alveolar system morphology	KMT2D KDM6A	3.64e-04	8	19	2	HP:0033137
HumanPheno	Anoperineal fistula	KMT2D KDM6A	3.64e-04	8	19	2	HP:0005218
HumanPheno	Anal fistula	KMT2D KDM6A	4.67e-04	9	19	2	HP:0010447
HumanPheno	Alobar holoprosencephaly	KMT2D KDM6A	4.67e-04	9	19	2	HP:0006988
HumanPheno	Pilomatrixoma	KMT2D KDM6A	4.67e-04	9	19	2	HP:0030434
HumanPheno	Abnormal proportion of memory T cells	KMT2D KDM6A	4.67e-04	9	19	2	HP:0032182
HumanPheno	Decreased circulating IgG2 concentration	KMT2D KDM6A	5.83e-04	10	19	2	HP:0008348
HumanPheno	Bronchiolitis	KMT2D KDM6A	5.83e-04	10	19	2	HP:0011950
HumanPheno	Absent nipple	KMT2D KDM6A	7.11e-04	11	19	2	HP:0002561
HumanPheno	Decreased circulating total IgG concentration	KMT2D KDM6A	7.11e-04	11	19	2	HP:0032132
HumanPheno	Partial anomalous pulmonary venous return	KMT2D KDM6A	7.11e-04	11	19	2	HP:0010773
MousePheno	abnormal retina horizontal cell morphology	GJA10 MEGF11 MEGF10	2.20e-05	19	41	3	MP:0006068
Domain	NHL	NHLRC1 TENM3	5.38e-04	13	50	2	PS51125
Domain	EGF_extracell	TENM3 MEGF11 MEGF10	5.55e-04	60	50	3	IPR013111
Domain	EGF_2	TENM3 MEGF11 MEGF10	5.55e-04	60	50	3	PF07974
Domain	EMI_domain	MEGF11 MEGF10	8.23e-04	16	50	2	IPR011489
Domain	EMI	MEGF11 MEGF10	9.31e-04	17	50	2	PS51041
Domain	hEGF	MEGF11 MEGF10	2.54e-03	28	50	2	PF12661
Domain	EGF	TENM3 MEGF11 MEGF10 GPR179	3.58e-03	235	50	4	SM00181
Domain	Laminin_EGF	MEGF11 MEGF10	3.95e-03	35	50	2	PF00053
Domain	EGF_Lam	MEGF11 MEGF10	3.95e-03	35	50	2	SM00180
Domain	Laminin_EGF	MEGF11 MEGF10	4.64e-03	38	50	2	IPR002049
Domain	-	NHLRC1 TENM3	4.89e-03	39	50	2	2.120.10.30
Domain	6-blade_b-propeller_TolB-like	NHLRC1 TENM3	6.74e-03	46	50	2	IPR011042
Domain	CUB	CSMD2 CSMD3	7.62e-03	49	50	2	PF00431
Domain	CUB	CSMD2 CSMD3	7.93e-03	50	50	2	SM00042
Pubmed	Binary Fate Choice between Closely Related Interneuronal Types Is Determined by a Fezf1-Dependent Postmitotic Transcriptional Switch.	TENM3 MEGF11 MEGF10	1.33e-06	15	51	3	31812516
Pubmed	Kabuki Syndrome	KMT2D KDM6A	2.11e-06	2	51	2	21882399
Pubmed	Hypermobility in individuals with Kabuki syndrome: The effect of growth hormone treatment.	KMT2D KDM6A	2.11e-06	2	51	2	30556359
Pubmed	Interferon Regulatory Factor 4 Inhibits Neointima Formation by Engaging Krüppel-Like Factor 4 Signaling.	IRF4 KLF4	2.11e-06	2	51	2	28851732
Pubmed	Identification of KMT2D and KDM6A mutations by exome sequencing in Korean patients with Kabuki syndrome.	KMT2D KDM6A	2.11e-06	2	51	2	24739679
Pubmed	MLL2 and KDM6A mutations in patients with Kabuki syndrome.	KMT2D KDM6A	2.11e-06	2	51	2	23913813
Pubmed	Fetuin-a to adiponectin ratio is a sensitive indicator for evaluating metabolic syndrome in the elderly.	ADIPOQ AHSG	2.11e-06	2	51	2	32252782
Pubmed	Identification of KMT2D and KDM6A variants by targeted sequencing from patients with Kabuki syndrome and other congenital disorders.	KMT2D KDM6A	2.11e-06	2	51	2	31935506
Pubmed	Association of fetuin-A to adiponectin ratio with metabolic syndrome: a cross-sectional study.	ADIPOQ AHSG	2.11e-06	2	51	2	28779425
Pubmed	Update of the genotype and phenotype of KMT2D and KDM6A by genetic screening of 100 patients with clinically suspected Kabuki syndrome.	KMT2D KDM6A	2.11e-06	2	51	2	32803813
Pubmed	Fetuin-A induces cytokine expression and suppresses adiponectin production.	ADIPOQ AHSG	2.11e-06	2	51	2	18335040
Pubmed	Prenatal and perinatal history in Kabuki Syndrome.	KMT2D KDM6A	2.11e-06	2	51	2	31654559
Pubmed	The phenotypic spectrum of Kabuki syndrome in patients of Chinese descent: A case series.	KMT2D KDM6A	2.11e-06	2	51	2	31883305
Pubmed	SETting up the genome: KMT2D and KDM6A genomic function in the Kabuki syndrome craniofacial developmental disorder.	KMT2D KDM6A	2.11e-06	2	51	2	37800171
Pubmed	Aberrant patterns of H3K4 and H3K27 histone lysine methylation occur across subgroups in medulloblastoma.	KMT2D KDM6A	2.11e-06	2	51	2	23184418
Pubmed	Kabuki syndrome genes KMT2D and KDM6A: functional analyses demonstrate critical roles in craniofacial, heart and brain development.	KMT2D KDM6A	2.11e-06	2	51	2	25972376
Pubmed	Prenatal Phenotype of Kabuki Syndrome: Seven Case Series.	KMT2D KDM6A	2.11e-06	2	51	2	36436503
Pubmed	The mammalian Ced-1 ortholog MEGF10/KIAA1780 displays a novel adhesion pattern.	MEGF11 MEGF10	2.11e-06	2	51	2	17498693
Pubmed	Clinical and molecular characterization study of Chinese Kabuki syndrome in Hong Kong.	KMT2D KDM6A	2.11e-06	2	51	2	33314698
Pubmed	Fetuin-A downregulates adiponectin through Wnt-PPARγ pathway in lipid induced inflamed adipocyte.	ADIPOQ AHSG	2.11e-06	2	51	2	27720679
Pubmed	Kabuki syndrome: clinical and molecular diagnosis in the first year of life.	KMT2D KDM6A	2.11e-06	2	51	2	25281733
Pubmed	Recurrent giant cell fibroblastoma: Malignancy predisposition in Kabuki syndrome revisited.	KMT2D KDM6A	2.11e-06	2	51	2	26898171
Pubmed	Molecular genetic analysis in 14 Czech Kabuki syndrome patients is confirming the utility of phenotypic scoring.	KMT2D KDM6A	2.11e-06	2	51	2	26841933
Pubmed	Congenital hyperinsulinism as the presenting feature of Kabuki syndrome: clinical and molecular characterization of 9 affected individuals.	KMT2D KDM6A	2.11e-06	2	51	2	29907798
Pubmed	Mechanisms linking obesity, chronic kidney disease, and fatty liver disease: the roles of fetuin-A, adiponectin, and AMPK.	ADIPOQ AHSG	2.11e-06	2	51	2	20150538
Pubmed	Sex hormone-binding globulin predicts the incidence of hyperglycemia in women: interactions with adiponectin levels.	ADIPOQ SHBG	2.11e-06	2	51	2	19429700
Pubmed	Kabuki syndrome: expanding the phenotype to include microphthalmia and anophthalmia.	KMT2D KDM6A	2.11e-06	2	51	2	26049589
Pubmed	Absence of deletion and duplication of MLL2 and KDM6A genes in a large cohort of patients with Kabuki syndrome.	KMT2D KDM6A	2.11e-06	2	51	2	22840376
Pubmed	Mutation Update for Kabuki Syndrome Genes KMT2D and KDM6A and Further Delineation of X-Linked Kabuki Syndrome Subtype 2.	KMT2D KDM6A	2.11e-06	2	51	2	27302555
Pubmed	Impact of the adipokine adiponectin and the hepatokine fetuin-A on the development of type 2 diabetes: prospective cohort- and cross-sectional phenotyping studies.	ADIPOQ AHSG	2.11e-06	2	51	2	24643166
Pubmed	Targeted inactivation of MLL3 histone H3-Lys-4 methyltransferase activity in the mouse reveals vital roles for MLL3 in adipogenesis.	KMT2D ADIPOQ KDM6A	3.33e-06	20	51	3	19047629
Pubmed	Mutually exclusive mutation profiles define functionally related genes in muscle invasive bladder cancer.	KMT2D KDM6A	6.32e-06	3	51	2	35073341
Pubmed	Leveraging the Mendelian disorders of the epigenetic machinery to systematically map functional epigenetic variation.	KMT2D KDM6A	6.32e-06	3	51	2	34463256
Pubmed	Identification of two new members of the CSMD gene family.	CSMD2 CSMD3	6.32e-06	3	51	2	12906867
Pubmed	Adiponectin upregulates SHBG production: molecular mechanisms and potential implications.	ADIPOQ SHBG	6.32e-06	3	51	2	24828613
Pubmed	Epigenetic Modulation in Periodontitis: Interaction of Adiponectin and JMJD3-IRF4 Axis in Macrophages.	ADIPOQ IRF4	6.32e-06	3	51	2	26399931
Pubmed	The KDM6A-KMT2D-p300 axis regulates susceptibility to diverse coronaviruses by mediating viral receptor expression.	KMT2D KDM6A	6.32e-06	3	51	2	37410700
Pubmed	Higher fetuin-A, lower adiponectin and free leptin levels mediate effects of excess body weight on insulin resistance and risk for myelodysplastic syndrome.	ADIPOQ AHSG	6.32e-06	3	51	2	24140093
Pubmed	The clinical phenotype of YWHAE-NUTM2B/E positive pediatric clear cell sarcoma of the kidney.	NUTM2E NUTM2B	6.32e-06	3	51	2	26542179
Pubmed	A UTX-MLL4-p300 Transcriptional Regulatory Network Coordinately Shapes Active Enhancer Landscapes for Eliciting Transcription.	KMT2D KDM6A	6.32e-06	3	51	2	28732206
Pubmed	Relationship of plasma adiponectin with sex hormone and insulin-like growth factor levels.	ADIPOQ SHBG	1.26e-05	4	51	2	17890489
Pubmed	Circulating levels of adiponectin, leptin, fetuin-A and retinol-binding protein in patients with tuberculosis: markers of metabolism and inflammation.	ADIPOQ AHSG	1.26e-05	4	51	2	22685600
Pubmed	Beyond conventional chemotherapy: Emerging molecular targeted and immunotherapy strategies in urothelial carcinoma.	KMT2D KDM6A	1.26e-05	4	51	2	26138514
Pubmed	Dissecting KMT2D missense mutations in Kabuki syndrome patients.	KMT2D KDM6A	2.10e-05	5	51	2	30107592
Pubmed	UTX and MLL4 coordinately regulate transcriptional programs for cell proliferation and invasiveness in breast cancer cells.	KMT2D KDM6A	2.10e-05	5	51	2	24491801
Pubmed	Glial precursors clear sensory neuron corpses during development via Jedi-1, an engulfment receptor.	MEGF11 MEGF10	4.41e-05	7	51	2	19915564
Pubmed	Cytoplasmic ACK1 interaction with multiple receptor tyrosine kinases is mediated by Grb2: an analysis of ACK1 effects on Axl signaling.	TNK2 ALK	4.41e-05	7	51	2	19815557
Pubmed	Knockdown of ALR (MLL2) reveals ALR target genes and leads to alterations in cell adhesion and growth.	KMT2D KDM6A	5.87e-05	8	51	2	17178841
Pubmed	The mutational landscape of lethal castration-resistant prostate cancer.	KMT2D KDM6A	5.87e-05	8	51	2	22722839
Pubmed	Physical Interactions and Functional Coordination between the Core Subunits of Set1/Mll Complexes and the Reprogramming Factors.	KMT2D KLF4	7.54e-05	9	51	2	26691508
Pubmed	Prediction of the coding sequences of unidentified human genes. XXI. The complete sequences of 60 new cDNA clones from brain which code for large proteins.	PKD1L2 CSMD2 CSMD3	1.11e-04	63	51	3	11572484
Pubmed	Klf4 expression in conventional dendritic cells is required for T helper 2 cell responses.	IRF4 KLF4	1.15e-04	11	51	2	25992862
Pubmed	Combinatorial CRISPR-Cas9 screens for de novo mapping of genetic interactions.	KMT2D KDM6A ALK	1.58e-04	71	51	3	28319113
Pubmed	The SCF-FBXW7 E3 ubiquitin ligase triggers degradation of histone 3 lysine 4 methyltransferase complex component WDR5 to prevent mitotic slippage.	KMT2D KDM6A	1.63e-04	13	51	2	36395886
Pubmed	Demethylation of H3K27 regulates polycomb recruitment and H2A ubiquitination.	KMT2D KDM6A	1.63e-04	13	51	2	17761849
Pubmed	The KMT2D Kabuki syndrome histone methylase controls neural crest cell differentiation and facial morphology.	KMT2D KDM6A	1.90e-04	14	51	2	32541010
Pubmed	The BRCT-domain containing protein PTIP links PAX2 to a histone H3, lysine 4 methyltransferase complex.	KMT2D KDM6A	2.19e-04	15	51	2	17925232
Pubmed	H3K4 mono- and di-methyltransferase MLL4 is required for enhancer activation during cell differentiation.	KMT2D KDM6A	2.50e-04	16	51	2	24368734
Pubmed	Foxi3 Deficiency Compromises Hair Follicle Stem Cell Specification and Activation.	KLF4 CDH3	2.83e-04	17	51	2	26992132
Pubmed	MLL3 and MLL4 Methyltransferases Bind to the MAFA and MAFB Transcription Factors to Regulate Islet β-Cell Function.	KMT2D KDM6A	2.83e-04	17	51	2	26180087
Pubmed	PTIP associates with MLL3- and MLL4-containing histone H3 lysine 4 methyltransferase complex.	KMT2D KDM6A	3.18e-04	18	51	2	17500065
Pubmed	Local protease signaling contributes to neural tube closure in the mouse embryo.	PRSS8 PRSS36	3.94e-04	20	51	2	20152175
Pubmed	FBXW7 Triggers Degradation of KMT2D to Favor Growth of Diffuse Large B-cell Lymphoma Cells.	KMT2D KDM6A	3.94e-04	20	51	2	32350066
Pubmed	Resetting the epigenetic balance of Polycomb and COMPASS function at enhancers for cancer therapy.	KMT2D KDM6A	3.94e-04	20	51	2	29785026
Pubmed	Mammalian embryo comparison identifies novel pluripotency genes associated with the naïve or primed state.	CA14 KLF4	4.35e-04	21	51	2	30026265
Pubmed	Congenital heart defect causing mutation in Nkx2.5 displays in vivo functional deficit.	CACNA1S ETV2	4.35e-04	21	51	2	28302382
Pubmed	Broad histone H3K4me3 domains in mouse oocytes modulate maternal-to-zygotic transition.	KMT2D KDM6A	4.35e-04	21	51	2	27626377
Pubmed	Structural basis for activity regulation of MLL family methyltransferases.	KMT2D KDM6A	4.78e-04	22	51	2	26886794
Pubmed	Putative complement control protein CSMD3 dysfunction impairs synaptogenesis and induces neurodevelopmental disorders.	TENM3 CSMD3	4.78e-04	22	51	2	35245678
Pubmed	Prediction of the coding sequences of unidentified human genes. XX. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	DCAF5 MEGF11 MEGF10	5.30e-04	107	51	3	11347906
Pubmed	WNT10A mutation causes ectodermal dysplasia by impairing progenitor cell proliferation and KLF4-mediated differentiation.	PAX9 KLF4	5.70e-04	24	51	2	28589954
Pubmed	Association between genetic variants in VEGF, ERCC3 and occupational benzene haematotoxicity.	NOL3 TP53I3 IRF4 GJA10	6.04e-04	263	51	4	19773279
Pubmed	ZNF750 Regulates Skin Barrier Function by Driving Cornified Envelope and Lipid Processing Pathways.	PRSS8 KLF4	6.19e-04	25	51	2	37660780
Pubmed	Klf4 glutamylation is required for cell reprogramming and early embryonic development in mice.	TTLL4 KLF4	6.19e-04	25	51	2	29593216
Pubmed	Positioning of five genes (CASK, ARX, SAT, IMAGE cDNAs 248928 and 253949) from the human X chromosome short arm with respect to evolutionary breakpoints on the mouse X chromosome.	CFP KDM6A	6.70e-04	26	51	2	10920247
Pubmed	Family-based analysis of candidate genes for polycystic ovary syndrome.	ADIPOQ SHBG	7.23e-04	27	51	2	20200332
Pubmed	Distinct transcriptomic changes in E14.5 mouse skeletal muscle lacking RYR1 or Cav1.1 converge at E18.5.	CACNA1S KLF4	8.35e-04	29	51	2	29543863
Pubmed	Identification and characterization of a novel human PP1 phosphatase complex.	KMT2D KDM6A	9.54e-04	31	51	2	20516061
Pubmed	Genetic associations for activated partial thromboplastin time and prothrombin time, their gene expression profiles, and risk of coronary artery disease.	ADIPOQ AHSG	1.08e-03	33	51	2	22703881
Pubmed	Delayed Hair Follicle Morphogenesis and Hair Follicle Dystrophy in a Lipoatrophy Mouse Model of Pparg Total Deletion.	ADIPOQ KLF4	1.08e-03	33	51	2	28964716
Pubmed	A quantitative analysis of the spatiotemporal pattern of transient receptor potential gene expression in the developing mouse cochlea.	TRPM4 PKD1L2	1.08e-03	33	51	2	19834762
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	NHSL1 TRPM4 KMT2D SZT2 TTLL4 TNK2 KLF4	1.10e-03	1105	51	7	35748872
Pubmed	A genome-wide association study (GWAS) for bronchopulmonary dysplasia.	TNK2 CSMD3	1.15e-03	34	51	2	23897914
Pubmed	MEGF10 and MEGF11 mediate homotypic interactions required for mosaic spacing of retinal neurons.	MEGF11 MEGF10	1.22e-03	35	51	2	22407321
Pubmed	Tracing the origin of hair follicle stem cells.	ADAMTS20 CDH3	1.22e-03	35	51	2	34108685
Pubmed	Genome-wide association study of d-amphetamine response in healthy volunteers identifies putative associations, including cadherin 13 (CDH13).	TENM3 CSMD2	1.43e-03	38	51	2	22952603
Interaction	KMT2C interactions	KMT2D IRF4 PAX9 KLF4 KDM6A	1.82e-05	134	49	5	int:KMT2C
Interaction	KDM6A interactions	KMT2D IRF4 PAX9 KLF4 KDM6A	4.52e-05	162	49	5	int:KDM6A
Interaction	KMT2D interactions	KMT2D IRF4 PAX9 KLF4 KDM6A	5.53e-05	169	49	5	int:KMT2D
Interaction	NFIA interactions	KMT2D IRF4 PAX9 KLF4 KDM6A	9.16e-05	188	49	5	int:NFIA
Cytoband	16q22.1	NOL3 KCTD19 CDH3	2.56e-04	110	51	3	16q22.1
Cytoband	3q27	ADIPOQ AHSG	3.57e-04	25	51	2	3q27
Cytoband	10q22.3	NUTM2E NUTM2B	1.06e-03	43	51	2	10q22.3
Cytoband	Ensembl 112 genes in cytogenetic band chr16q22	NOL3 KCTD19 CDH3	1.13e-03	183	51	3	chr16q22
Cytoband	19q13.12	DMKN ETV2	2.94e-03	72	51	2	19q13.12
Cytoband	17p13.3	WDR81 RILP	4.36e-03	88	51	2	17p13.3
Cytoband	Ensembl 112 genes in cytogenetic band chr17p13	SHBG WDR81 RILP	6.76e-03	346	51	3	chr17p13
Cytoband	Ensembl 112 genes in cytogenetic band chr3q27	ADIPOQ AHSG	8.99e-03	128	51	2	chr3q27
Coexpression	MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3	NOL3 ETV2 CA14 PRSS36 MEGF10	4.49e-06	125	51	5	M1969
Coexpression	MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3	NOL3 ETV2 CA14 PRSS36 MEGF10	5.86e-06	132	51	5	MM841
CoexpressionAtlas	Progenitor-Cell-Biology-Consortium_StemCell_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_1000	PRSS8 GLS2 DMKN ADAMTS20 IRF4 CA14 BEND4 PKD1L2 CSMD2 CDH3 MEGF10	1.18e-05	986	49	11	PCBC_SC_fibroblast_1000
CoexpressionAtlas	Progenitor-Cell-Biology-Consortium_StemCell_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_1000	PRSS8 GLS2 DMKN ADAMTS20 CA14 BEND4 PKD1L2 CSMD2 CDH3 MEGF11 MEGF10	1.26e-05	993	49	11	PCBC_SC_blastocyst_1000
CoexpressionAtlas	AravindRamakr_StemCell_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_1000_k-means-cluster#2	PRSS8 GLS2 DMKN ADAMTS20 CA14 BEND4 CSMD2 MEGF10	3.59e-05	554	49	8	Arv_SC_fibroblast_1000_K2
CoexpressionAtlas	AravindRamakr_StemCell-HD_top-relative-expression-ranked_1000_k-means-cluster#1	PRSS8 GLS2 DMKN ADAMTS20 CA14 BEND4 CSMD2 MEGF10	3.73e-05	557	49	8	Arv_SC-HD_1000_K1
CoexpressionAtlas	AravindRamakr_StemCell-LF_top-relative-expression-ranked_1000	PRSS8 GLS2 DMKN ADAMTS20 CA14 BEND4 PKD1L2 CSMD2 CDH3 MEGF10	6.66e-05	980	49	10	Arv_SC-LF_1000
CoexpressionAtlas	Progenitor-Cell-Biology-Consortium_StemCell_CD34+_top-relative-expression-ranked_1000	PRSS8 GLS2 DMKN ADAMTS20 CA14 BEND4 PKD1L2 CSMD2 CDH3 MEGF10	6.89e-05	984	49	10	PCBC_SC_CD34+_1000
CoexpressionAtlas	Progenitor-Cell-Biology-Consortium_StemCell_top-relative-expression-ranked_1000	PRSS8 GLS2 DMKN ADAMTS20 IRF4 CA14 BEND4 CSMD2 CDH3 MEGF10	7.19e-05	989	49	10	PCBC_SC_1000
CoexpressionAtlas	AravindRamakr_StemCell-LF_top-relative-expression-ranked_1000_k-means-cluster#3	PRSS8 GLS2 DMKN ADAMTS20 CA14 BEND4 CSMD2 MEGF10	1.43e-04	675	49	8	Arv_SC-LF_1000_K3
CoexpressionAtlas	AravindRamakr_StemCell_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_2500_k-means-cluster#2	GLS2 DMKN ADAMTS20 IRF4 CA14 BEND4 CSMD2 KDM6A MEGF11 MEGF10	1.83e-04	1108	49	10	Arv_SC_fibroblast_2500_K2
CoexpressionAtlas	AravindRamakr_StemCell-HD_top-relative-expression-ranked_2500_k-means-cluster#2	GLS2 DMKN ADAMTS20 IRF4 CA14 BEND4 CSMD2 KDM6A MEGF11 MEGF10	1.90e-04	1113	49	10	Arv_SC-HD_2500_K2
CoexpressionAtlas	AravindRamakr_StemCell-H9hpx_top-relative-expression-ranked_2500_k-means-cluster#5	PRSS8 GLS2 DMKN ADAMTS20 IRF4 CA14 BEND4 CSMD2 MEGF10	3.58e-04	981	49	9	Arv_SC-H9hpx_2500_K5
CoexpressionAtlas	AravindRamakr_StemCell_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_500_k-means-cluster#1	PRSS8 DMKN ADAMTS20 BEND4 MEGF10	3.67e-04	267	49	5	Arv_SC_fibroblast_500_K1
CoexpressionAtlas	AravindRamakr_StemCell-HD_top-relative-expression-ranked_500_k-means-cluster#3	PRSS8 DMKN ADAMTS20 BEND4 MEGF10	3.67e-04	267	49	5	Arv_SC-HD_500_K3
CoexpressionAtlas	AravindRamakr_StemCell-HD_top-relative-expression-ranked_1000	PRSS8 GLS2 DMKN ADAMTS20 CA14 BEND4 PKD1L2 CSMD2 MEGF10	3.72e-04	986	49	9	Arv_SC-HD_1000
CoexpressionAtlas	AravindRamakr_StemCell_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_1000	PRSS8 GLS2 DMKN ADAMTS20 CA14 BEND4 PKD1L2 CSMD2 MEGF10	3.72e-04	986	49	9	Arv_SC_fibroblast_1000
ToppCell	367C-Epithelial_cells-Epithelial-H_(AT1)-\|367C / Donor, Lineage, Cell class and subclass (all cells)	PRSS8 GLS2 DMKN PAX9 CDH3	2.43e-06	188	51	5	61422c7919ca0ea02d6be4302f11b169a3ce35e5
ToppCell	367C-Epithelial_cells-Epithelial-H_(AT1)\|367C / Donor, Lineage, Cell class and subclass (all cells)	PRSS8 GLS2 DMKN PAX9 CDH3	2.43e-06	188	51	5	18698f0b22ccbc2b93759acc1c8dbdb30a6b5a16
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	LMF1 TNK2 CSMD2 CSMD3 MEGF11	3.21e-06	199	51	5	333056c2abe9724efeab542c0365fcfe4eff8f18
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	LMF1 TNK2 CSMD2 CSMD3 MEGF11	3.21e-06	199	51	5	e60ecbb8fa7bcd3e2ce7d78f6efb2cfd1fd77698
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW23-Neuronal-Intermediate\|GW23 / Sample Type, Dataset, Time_group, and Cell type.	TRPM4 TENM3 WDR81 CSMD3 MEGF10	3.28e-06	200	51	5	fe772d98c461c973dfc082e1fc50117c27ced804
ToppCell	COVID-19-kidney-Technical/muscle_(Mes)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ADAMTS20 CSMD2 CSMD3 ALK	2.49e-05	148	51	4	d6ac5972267254651dfbe16bb4e9a62228093cc7
ToppCell	droplet-Lung-nan-3m-Myeloid-Myeloid_Dendritic_Type_1\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IRF4 CFP BEND4 PKD1L2	3.55e-05	162	51	4	8a488ecd25ef41468c3c7766eb936dbc2f7665a9
ToppCell	droplet-Marrow-nan-24m-Lymphocytic-late_pro-B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1S PRSS8 NOL3 IRF4	4.69e-05	174	51	4	cdfc50e5383c8670ce5109736aff36406f46c03d
ToppCell	droplet-Marrow-BM-1m-Lymphocytic-late_pro-B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1S LMF1 ETV2 IRF4	4.90e-05	176	51	4	2e9073166da4d9fae70ba4f3fdcad35523caf7cd
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_acinar_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRSS8 ADIPOQ GLS2 PKD1L2	4.90e-05	176	51	4	60740f676db5d259ef3046bd5bc7b7b14924ecee
ToppCell	343B-Fibroblasts-Fibroblast-B_(Myofibroblast)\|343B / Donor, Lineage, Cell class and subclass (all cells)	TENM3 ZNF229 MEGF11 KLHL22	5.01e-05	177	51	4	e55d21d4d61a069b9bbe0e7595fbfb7cfbacfd87
ToppCell	343B-Fibroblasts-Fibroblast-B_(Myofibroblast)-\|343B / Donor, Lineage, Cell class and subclass (all cells)	TENM3 ZNF229 MEGF11 KLHL22	5.01e-05	177	51	4	43ba6f12c2fb32698a420bf799d46ac1b558f146
ToppCell	18-Airway-Epithelial-Submucosal_gland_basal\|Airway / Age, Tissue, Lineage and Cell class	PRSS8 BEND4 PAX9 CDH3	5.46e-05	181	51	4	33938e6521712058312879f84f4ae381c2bfc379
ToppCell	wk_15-18-Epithelial-Distal_epithelial-epi-tip_early\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	PRSS8 KCTD19 DMKN CDH3	6.33e-05	188	51	4	eefd2930833d216efbd72f67541bb2d9e7d47f3b
ToppCell	15-Airway-Epithelial-Basal_cell\|Airway / Age, Tissue, Lineage and Cell class	PRSS8 GLS2 PAX9 CDH3	6.46e-05	189	51	4	f128c2fc37f232d193de18a922c47fdd70e1982d
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Classical_Monocyte-Mono_c2-CD14-HLA-DPB1\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	TP53I3 CFP RILP KLF4	6.59e-05	190	51	4	4b9bac17eb7ceadada932f2d4a20a5f176088d53
ToppCell	PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating1_(8)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	PRSS8 KCTD19 DMKN CDH3	7.01e-05	193	51	4	979980369d2dbee9dc4770d72b93037abd7786eb
ToppCell	wk_20-22-Epithelial-Distal_epithelial-type_II_pneumocyte\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	NHSL1 PRSS8 DMKN CDH3	7.29e-05	195	51	4	45d1acd316d0ced97dfb150c3a943128d8fa4e7e
ToppCell	wk_15-18-Epithelial-Distal_epithelial-type_II_pneumocyte\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	NHSL1 PRSS8 DMKN CDH3	7.29e-05	195	51	4	0e3aac1b1a1fd483f5fb9a394eb90c0e1ce63542
ToppCell	facs-Lung-18m-Epithelial-airway_epithelial\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PRSS8 DMKN PAX9 CDH3	7.29e-05	195	51	4	ed052c6d3dc104b02e34b645abfdee477af050c6
ToppCell	wk_20-22-Epithelial-Distal_epithelial\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	NHSL1 PRSS8 DMKN CDH3	7.44e-05	196	51	4	cd507ee2baf4f52d6498811b3510d3164b56311f
ToppCell	wk_20-22-Epithelial-Distal_epithelial-type_I_pneumocyte\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	NHSL1 PRSS8 DMKN CDH3	7.44e-05	196	51	4	e24a7aaf41793abba66c1189d933ca05b14c1af9
ToppCell	wk_15-18-Epithelial-Distal_epithelial\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	NHSL1 PRSS8 DMKN CDH3	7.58e-05	197	51	4	b7aff83c27606d87565382a768119a863fe1c294
ToppCell	tumor_Lung-Epithelial_cells-tS1\|tumor_Lung / Location, Cell class and cell subclass	PRSS8 NOL3 DMKN MEGF11	7.58e-05	197	51	4	8336e6647604e4bdd1596ea554c22203d13782e9
ToppCell	PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^medium_distal_(2)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	PRSS8 KCTD19 DMKN MEGF11	7.58e-05	197	51	4	2f91b3870a7058168093a143110954c07588cfe9
ToppCell	wk_15-18-Epithelial-Airway_epithelial_progenitor\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	NHSL1 PRSS8 DMKN CDH3	7.73e-05	198	51	4	c477405b093f4e5374e57bcacf1fb204a0f7eb3b
ToppCell	wk_15-18-Epithelial\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	NHSL1 PRSS8 DMKN CDH3	7.73e-05	198	51	4	12bbe77c3d68bf1e545949dbb1eb49ed3641de3d
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	TNK2 CSMD2 CSMD3 MEGF11	7.89e-05	199	51	4	19a97e27a4758e794ce7246d295e112b47931a48
ToppCell	wk_08-11-Epithelial-Airway_epithelial_progenitor-epi-stalk_intermediate\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	NHSL1 PRSS8 DMKN CDH3	7.89e-05	199	51	4	debdd7dba774d9ccff7effc3f4c132393d203dfa
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-F\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	LMF1 TNK2 CSMD3 MEGF11	8.04e-05	200	51	4	ad777683adeb2ce45ade570386235e311fa7ea2d
ToppCell	Macroglial-Polydendrocytes-PDGFRA---\|Macroglial / cells hierarchy compared to all cells using T-Statistic	TNK2 CSMD2 CSMD3 MEGF11	8.04e-05	200	51	4	4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca
ToppCell	Macroglial-Polydendrocytes-PDGFRA-\|Macroglial / cells hierarchy compared to all cells using T-Statistic	TNK2 CSMD2 CSMD3 MEGF11	8.04e-05	200	51	4	f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2
ToppCell	Macroglial-Polydendrocytes-PDGFRA--\|Macroglial / cells hierarchy compared to all cells using T-Statistic	TNK2 CSMD2 CSMD3 MEGF11	8.04e-05	200	51	4	cc3409518f8b436ea92deb955e81114b3f410ff7
ToppCell	Tracheal-10x5prime-Epithelial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	PRSS8 DMKN PAX9 CDH3	8.04e-05	200	51	4	efd461c687155c84ef590352207e6fe4ba392a90
ToppCell	Macroglial-Polydendrocytes-PDGFRA----L1-6\|Macroglial / cells hierarchy compared to all cells using T-Statistic	TNK2 CSMD2 CSMD3 MEGF11	8.04e-05	200	51	4	310cd53db1c137f6af74e6ae682221d7ac27310c
ToppCell	Macroglial-Polydendrocytes-PDGFRA\|Macroglial / cells hierarchy compared to all cells using T-Statistic	TNK2 CSMD2 CSMD3 MEGF11	8.04e-05	200	51	4	c24a3099e3d96d8b72f6d05286bb355d661a0377
ToppCell	wk_08-11-Epithelial\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	NHSL1 PRSS8 DMKN CDH3	8.04e-05	200	51	4	445fc7995ffc440c6256a6aab0bbf33fb0fea028
ToppCell	Macroglial-Polydendrocytes\|Macroglial / cells hierarchy compared to all cells using T-Statistic	TNK2 CSMD2 CSMD3 MEGF11	8.04e-05	200	51	4	961858738ce35db8760c8c2e136f8369bc444ccf
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD4+_T-Treg-Treg_3\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ADIPOQ AHSG CLBA1	1.88e-04	97	51	3	442201932dc318846dc45f6c753e30b0d9a69f73
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD4+_T-Treg-Treg_3\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	ADIPOQ AHSG CLBA1	2.05e-04	100	51	3	c50714a0819a40917d7a360623220576473f52ad
ToppCell	10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_monocytic-non-classical_monocyte\|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	ZNF229 CSMD2 CSMD3	2.58e-04	108	51	3	695ed3f8cf637d767a6d79b0309d5ee82dfd063f
ToppCell	E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-matrix_-_immature_2\|E16.5-samps / Age Group, Lineage, Cell class and subclass	ETV2 ADAMTS20 GJA10	2.94e-04	113	51	3	dc002185095590fc071b2f39259f8b87a757e174
ToppCell	LPS-IL1RA-Epithelial_alveolar-Mes-Like-AT1-AT2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GLS2 CDH3 CLBA1	4.24e-04	128	51	3	082b3dc312b033c9b21cf73499009a1dc049ee2b
ToppCell	COVID-19-kidney-Epithelial_Doublet\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ADAMTS20 CSMD3 ALK	4.44e-04	130	51	3	1ff28e9d3dc9a791e07d815f8fbb48f75d3f275b
ToppCell	ASK454-Epithelial-Type_2\|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq	GLS2 NOL3 TSSC4	5.06e-04	136	51	3	ff9a5e111993fdb3ac64c5ef269e3460ff994517
ToppCell	TCGA-Uvea\|World / Sample_Type by Project: Shred V9	WDR81 IRF4 CA14	5.62e-04	141	51	3	015451a83087f2705d3315ebc8f23797c6f10ed6
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Stem_cells\|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type.	SHBG KLF4 PRSS36	5.86e-04	143	51	3	0118772a5bc7c48465e9b314be55203412e8d67c
ToppCell	Mild/Remission-B_naive-13\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	NHLRC1 CA14 KLF4	6.10e-04	145	51	3	7827aef87f834cd0d19780417757c9386e19b22e
ToppCell	COVID-19-kidney-Technical/muscle_(PCT)\|kidney / Disease (COVID-19 only), tissue and cell type	C16orf90 CSMD2 CSMD3	6.22e-04	146	51	3	c55f1bdb6ac43b4118cb27ea7c879527e1afcbab
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-DC-cDC2-A\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	TRPM4 IRF4 CFP	6.34e-04	147	51	3	c5913cc351577e54536dd239a33e5f7a5cb79672
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-3\|TCGA-Brain / Sample_Type by Project: Shred V9	SZT2 ADAMTS20 CSMD2	6.60e-04	149	51	3	768877bade04ca0321593b8470b5011ad8270431
ToppCell	390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	ETV2 CSMD2 CDH3	6.60e-04	149	51	3	68661c8facfb638560bb2e2c20d509941286dacb
ToppCell	COVID-19-kidney-Technical/muscle_(Imm)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ADAMTS20 CSMD3 ALK	6.73e-04	150	51	3	0205318a870e091add66ee4305747dda9f51510d
ToppCell	BAL-Mild-Myeloid-TRAM-TRAM2-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	NHSL1 TTLL4 KLF4	6.86e-04	151	51	3	28e3f77d2edb30fcf1414762a55ceffaf879d526
ToppCell	BAL-Mild-Myeloid-TRAM-TRAM2\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	NHSL1 TTLL4 KLF4	6.86e-04	151	51	3	688cc5e4d46ba16f9b431352d7a6d39b21941e9c
ToppCell	BAL-Mild-Myeloid-TRAM-TRAM2-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	NHSL1 TTLL4 KLF4	6.86e-04	151	51	3	45392bb1c6358beff33da0ca84f7696fb5824f30
ToppCell	BAL-Mild-Myeloid-TRAM-TRAM2\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	NHSL1 TTLL4 KLF4	6.86e-04	151	51	3	3d861285c71abe220b19a069eb9876199c6c8f39
ToppCell	COVID-19-Heart-Adipocyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ADIPOQ TENM3 MEGF10	7.12e-04	153	51	3	93958bd9c951222ba5b740d1cb83fd5d78a10e1e
ToppCell	390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3\|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells)	ETV2 CSMD2 CDH3	7.26e-04	154	51	3	1c62290a2558fd6401b27de5a867d243b143b00a
ToppCell	Mild_COVID-19-Myeloid-TRAM2\|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30）	NHSL1 TTLL4 KLF4	7.26e-04	154	51	3	ab648f6b29eb9e499e46cbdbaf3c5cf6b94d1f64
ToppCell	Basal_cells-Donor_06\|World / lung cells shred on cell class, cell subclass, sample id	SHBG PAX9 CDH3	7.82e-04	158	51	3	dd069a822e9698e6dddc155d9a5b52383f7879d5
ToppCell	10x5'-Lung-Lymphocytic_B-ABC_aged-B_memory\|Lung / Manually curated celltypes from each tissue	DMKN BEND4 ZNF229	7.96e-04	159	51	3	d3202ddc291b8686dbe67690df13c7daffec2199
ToppCell	18-Airway-Epithelial-Bud_tip_progenitor\|Airway / Age, Tissue, Lineage and Cell class	NHSL1 PRSS8 CA14	7.96e-04	159	51	3	e715cadff8e7d5ebe4c2198dbdfd3ca41ecb8a6a
ToppCell	COVID-19-kidney-Technical/muscle_(Mes)\|kidney / Disease (COVID-19 only), tissue and cell type	CSMD2 CSMD3 ALK	7.96e-04	159	51	3	5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Neural-neural_cell-Schwann_Cell_/_Neural\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TENM3 CSMD2 MEGF10	8.26e-04	161	51	3	7d1bc73f4c82465b3f489d6737048b0cd54f22cf
ToppCell	droplet-Lung-immune-endo-depleted-3m-Myeloid-plasmacytoid_dendritic_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IRF4 CFP PRSS36	8.26e-04	161	51	3	ed93cb6c133855a5c244821e1a260aae8ab4df9a
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Neural-neural_cell-Schwann_Cell_/_Neural-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TENM3 CSMD2 MEGF10	8.26e-04	161	51	3	410eef62c83c704cbfc5a1b643c4db11bbdcd81f
ToppCell	facs-Pancreas-Exocrine-24m-Epithelial-pancreatic_acinar_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GLS2 ADAMTS20 CSMD3	8.26e-04	161	51	3	b9a17f41426bf715f30bf544a6795afaf37a3aa6
ToppCell	droplet-Lung-immune-endo-depleted-3m-Myeloid-Plasmacytoid_Dendritic\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IRF4 CFP PRSS36	8.26e-04	161	51	3	0089d7bb305c592392791862a3341fc92af8f3e2
ToppCell	facs-Pancreas-Exocrine-24m-Epithelial-pancreatic_acinar_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GLS2 ADAMTS20 CSMD3	8.26e-04	161	51	3	f7a89c481f789f624102857be722c95fbeb47595
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Neural\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TENM3 CSMD2 MEGF10	8.26e-04	161	51	3	71022485da6754a2b57b4c3e758e3de4c95cc292
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Neural-neural_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TENM3 CSMD2 MEGF10	8.26e-04	161	51	3	59ae8a7c9a04ecaa335b8064852a5a91a21780bd
ToppCell	frontal_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_ALM_Oprk1\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	NHSL1 TENM3 DMKN	8.41e-04	162	51	3	2d28306c6125b31f11ea6d911a167b93a74907c5
ToppCell	droplet-Lung-nan-18m-Lymphocytic-plasma_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1S AHSG IRF4	8.56e-04	163	51	3	5efecdd8a069a822bc9d35b407092925a865e629
ToppCell	facs-Lung-3m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l15\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CFP BEND4 PKD1L2	8.56e-04	163	51	3	f558ad9569e5137e62a601ba4f073e69ed8f8650
ToppCell	droplet-Lung-nan-18m-Lymphocytic-Plasma_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1S AHSG IRF4	8.56e-04	163	51	3	0d94a427f86e62aba12c397c6d7b8cd297f3a0e5
ToppCell	droplet-Lung-18m-Hematologic-lymphocytic-plasma_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CACNA1S AHSG IRF4	8.71e-04	164	51	3	b92e7c91910d518627376166c6ea9ed333b3d07e
ToppCell	droplet-Lung-18m-Hematologic-lymphocytic-plasma_cell-plasma_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CACNA1S AHSG IRF4	8.71e-04	164	51	3	a1e43c6b3e2553f5604100db6e92bf244b70c36d
ToppCell	PND14-Immune-Immune_Myeloid-DC-maDC\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CACNA1S GLS2 BEND4	8.86e-04	165	51	3	1c3709ac9f96ace1f3b28e1f2f15b4a8d65885ca
ToppCell	facs-Lung-EPCAM-3m-Myeloid-Myeloid_Dendritic_Type_1\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IRF4 CFP BEND4	8.86e-04	165	51	3	2477b0f1a0ea26184cf3cc4a9ffcdfa825cbc615
ToppCell	PND14-Immune-Immune_Myeloid-DC-maDC-maDC_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CACNA1S GLS2 BEND4	8.86e-04	165	51	3	fbc7d97e6f30975d35c76a7c97947a34cf5975d2
ToppCell	LV-16._Neuronal\|World / Chamber and Cluster_Paper	TENM3 ALK MEGF10	8.86e-04	165	51	3	6ed52cb756d21addf46c7f6c457458b01339fe04
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DMKN IRF4 CSMD3	9.02e-04	166	51	3	3b67064a5149e72f895344d938c64b8ff65247f5
ToppCell	PND07-Epithelial-Epithelial_Airway-Basal-Basal-Basal_prolif\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	GLS2 DMKN PAX9	9.18e-04	167	51	3	29d271643f3a1718b53db77b7d093ec94225a824
ToppCell	facs-Aorta-Heart-24m-Myeloid-leukocyte\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IRF4 CFP BEND4	9.18e-04	167	51	3	b85fd7ab21c80470bca804c788ce49a2bce763f8
ToppCell	ILEUM-non-inflamed-(3)_MNP-(3)_pDC\|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	GLS2 IRF4 BEND4	9.18e-04	167	51	3	8ddf9da71a7c4ed53588435db826563a24cee616
ToppCell	mild_COVID-19_(asymptomatic)-pDC\|World / disease group, cell group and cell class (v2)	TRPM4 KCTD19 IRF4	9.18e-04	167	51	3	bf08f17965a4dd03f371b4ed0ab0d5e62ed61307
ToppCell	facs-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell-myeloid_dendritic_type_1\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	IRF4 CFP BEND4	9.18e-04	167	51	3	fd84a99ea142d1684cdcf4a88ef1d541760bc78a
ToppCell	PND07-Epithelial-Epithelial_Airway-Basal-Basal-Basal_G2M\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DMKN PAX9 CDH3	9.34e-04	168	51	3	f150beee37e0252951a88adcd9e3f0a22e5cfdd9
ToppCell	COVID-19-Heart-Neuronal\|COVID-19 / Disease (COVID-19 only), tissue and cell type	TENM3 ALK MEGF10	9.34e-04	168	51	3	88c2c574f428c2502b5fe099bd73b0758f668ef6
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m-Myeloid-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DMKN IRF4 PAX9	9.34e-04	168	51	3	29a6c3ba69e03ccb19efb8ac177b9a162dc1ea43
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m-Myeloid\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DMKN IRF4 PAX9	9.34e-04	168	51	3	4297be958a4754677df7cf73feba19b0d76f1b4a
ToppCell	droplet-Lung-1m-Hematologic-myeloid-myeloid_dendritic_cell\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CACNA1S CFP BEND4	9.34e-04	168	51	3	99148986aa5628f67d85258c171b254be77a071c
ToppCell	COVID-19-Heart-Adipocyte\|Heart / Disease (COVID-19 only), tissue and cell type	ADIPOQ TENM3 MEGF10	9.50e-04	169	51	3	bd39f85b48207955f80ca120a11e15a0124117b9
ToppCell	facs-Lung-Endomucin-24m-Endothelial-vein_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SHBG CA14 KLF4	9.50e-04	169	51	3	d2862a7ddee6d7a65d84ef9d0800ba6f4690973f
ToppCell	facs-Lung-Endomucin-24m-Endothelial-Vein_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SHBG CA14 KLF4	9.50e-04	169	51	3	8dba7546adc6b1345933eec81fc77fc9611fae60
ToppCell	droplet-Kidney-nan-21m-Lymphocytic-CD45____B_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1S IRF4 CFP	9.50e-04	169	51	3	d44fc49056799dfc70a3c7d538c210d88ffded05
ToppCell	droplet-Kidney-nan-21m-Lymphocytic-B_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1S IRF4 CFP	9.66e-04	170	51	3	53fd50c9a27d47662fbcbd7e9e9837f72ac448c5
ToppCell	facs-Marrow-T-cells-3m-Myeloid-promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CFP GJA10 KLF4	9.66e-04	170	51	3	a78d9789c3e7c84a36e1bd380192d7aba4a4d443
ToppCell	droplet-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell-myeloid_dendritic_type_1\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CFP BEND4 PKD1L2	9.66e-04	170	51	3	138235227fc4c3d660c3a06e8e5167bf64f076b3
Disease	Kabuki syndrome 1	KMT2D KDM6A	2.70e-06	2	49	2	cv:CN030661
Disease	Kabuki syndrome (is_implicated_in)	KMT2D KDM6A	2.70e-06	2	49	2	DOID:0060473 (is_implicated_in)
Disease	KABUKI SYNDROME 1	KMT2D KDM6A	2.70e-06	2	49	2	147920
Disease	Kabuki syndrome (implicated_via_orthology)	KMT2D KDM6A	8.10e-06	3	49	2	DOID:0060473 (implicated_via_orthology)
Disease	Kabuki make-up syndrome	KMT2D KDM6A	1.62e-05	4	49	2	C0796004
Disease	Clear cell sarcoma of kidney	NUTM2E NUTM2B	4.04e-05	6	49	2	C0334488
Disease	Conventional (Clear Cell) Renal Cell Carcinoma	ADIPOQ CSMD3 KDM6A ALK	1.08e-04	148	49	4	C0279702
Disease	BMI-adjusted adiponectin measurement	ADIPOQ ALK	2.80e-04	15	49	2	EFO_0007737
Disease	gestational diabetes (is_marker_for)	ADIPOQ AHSG	3.62e-04	17	49	2	DOID:11714 (is_marker_for)
Disease	Metabolic Syndrome X	ADIPOQ SHBG	5.56e-04	21	49	2	C0524620
Disease	lung small cell carcinoma (is_implicated_in)	KMT2D KDM6A	9.93e-04	28	49	2	DOID:5409 (is_implicated_in)
Disease	Papillary Renal Cell Carcinoma	ADIPOQ CSMD3 ALK	1.27e-03	128	49	3	C1306837
Disease	Renal Cell Carcinoma	ADIPOQ CSMD3 ALK	1.27e-03	128	49	3	C0007134
Disease	Sarcomatoid Renal Cell Carcinoma	ADIPOQ CSMD3 ALK	1.27e-03	128	49	3	C1266043
Disease	Chromophobe Renal Cell Carcinoma	ADIPOQ CSMD3 ALK	1.27e-03	128	49	3	C1266042
Disease	Collecting Duct Carcinoma of the Kidney	ADIPOQ CSMD3 ALK	1.27e-03	128	49	3	C1266044
Disease	lung non-small cell carcinoma (is_implicated_in)	KMT2D RASSF1 KDM6A	1.61e-03	139	49	3	DOID:3908 (is_implicated_in)
Disease	Bladder Neoplasm	KMT2D RASSF1 KDM6A	1.64e-03	140	49	3	C0005695

Protein segments in the cluster

Peptide	Gene	Start	Entry
PPSHCDPGAASSWAG	nan	221	Q6ZR03
LDGHWTGSLPHCSGT	CSMD2	2816	Q7Z408
QLNGHWSGSQPHCSG	CSMD3	3036	Q7Z407
CTGWMAGIPGHPGHN	ADIPOQ	36	Q15848
QLHVHSPCPWAGSAG	GJA10	331	Q969M2
SPCPWAGSAGNQHLG	GJA10	336	Q969M2
GGWTSPATSESHGHP	BEND4	291	Q6ZU67
HSAQHGPGSGAPWLR	C5orf38	46	Q86SI9
QVGPWGPCTTTCGHG	ADAMTS20	1081	P59510
GHGDSDPRHCWGFPD	TNK2	466	Q07912
EQAGCHLLGSWGPAH	TNK2	1021	Q07912
SGHVAELGPGCQGHW	TP53I3	66	Q53FA7
GHRFQPAGPATHTWC	RASSF1	51	Q9NS23
PGHQHGQEPEWATAG	RILP	201	Q96NA2
CRGLCTNPGHWGSHP	KCTD19	591	Q17RG1
HPTTGHCRCLPGWSG	MEGF10	551	Q96KG7
HHITGECACPPGWTG	MEGF11	241	A6BM72
GWQHAGGTSLSPHNC	PAX9	301	P55771
AGEPCVCWPHFGTHG	KLF4	376	O43474
MTFGPRGHHWQGPAC	IRF4	196	Q15306
ACPWGSVGPGACSQH	GPR179	1761	Q6PRD1
GNPSGWHSSSRGHDG	GPBP1L1	91	Q9HC44
SDNWSGGHAVSHPPV	KDM6A	446	O15550
GDPQSPGRHWNEGHA	NHSL1	466	Q5SYE7
PSNGPGHEHSSHAWA	DCAF5	741	Q96JK2
SHCGRGGWGHPSRSP	GLS2	16	Q9UI32
PWTPCSASCHGGPHE	CFP	201	P27918
WHGGQAAAAPDTCGH	PKD1L2	116	Q7Z442
SGSPHWPTGGSNLCP	PRSS36	816	Q5K4E3
SGQWSSVCPLPAGHG	KLHL22	521	Q53GT1
PGHNGAWETSGGHGI	DMKN	136	Q6E0U4
CRGGWPGPNHGITHF	CACNA1S	261	Q13698
AQLWGCHSAPHGPGL	AHSG	11	P02765
HGAPTGSEAGANWNH	GALT	301	P07902
SHPPPTGQCESHWLG	C16orf90	71	A8MZG2
AGPDCTTSWNPGLHA	ETV2	186	O00321
GPHGQDHWPASYPEC	CA14	26	Q9ULX7
HGHVETCPGPWKGGF	CDH3	641	P22223
PGALTCHHTFGGWGT	NHLRC1	111	Q6VVB1
CHHTFGGWGTLVNPT	NHLRC1	116	Q6VVB1
GNAGPWPQGAHGESS	NUTM2B	296	A6NNL0
GNAGPWPQGAHGESS	NUTM2E	296	B1AL46
QPGGSHGEPSSAAWA	SZT2	1786	Q5T011
WTHSCPQSPGNGTDA	SHBG	386	P04278
GHWTPEAPGSGTTCP	NOL3	111	O60936
SFPNGLHCTVTGWGH	PRSS8	161	Q16651
VHWLFTTCGASGPHG	ALK	681	Q9UM73
SHQPCQGGPWVTGTS	CLBA1	121	Q96F83
AGPGSPEAEEWGSHH	TSSC4	261	Q9Y5U2
IHGECHCSPGWGGSN	TENM3	626	Q9P273
DAAPHQGWEGASTPC	ZNF229	136	Q9UJW7
SWHHSGGTGDCAPQP	TTLL4	251	Q14679
SNCSSEPGFWAHPPG	TRPM4	991	Q8TD43
EWDPHGGGCPQDDGH	WDR81	1541	Q562E7
CHPQAPGGSSTWAPS	nan	46	Q6ZTC4
PAHLGEPGGSCWAHH	KMT2D	126	O14686
GPAGSPAHLHTGTFW	LMF1	36	Q96S06